Laddar...
The emerging landscape of immune checkpoint inhibitor based clinical trials in adults with advanced rare tumors
“Rare cancers” are a diverse collection of cancers that collectively account for approximately 20% of all adult cancers in the United States. Their rarity has caused an underrepresentation of these cancers in preclinical research and clinical trials, leading to fewer (and often no) treatment options...
Sparad:
| I publikationen: | Hum Vaccin Immunother |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189105/ https://ncbi.nlm.nih.gov/pubmed/33325769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1854604 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|